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Abstract
Background: Poor response is a major concern in public health surveys. In a population-based ORISCAV-LUX study
carried out in Grand-Duchy of Luxembourg to assess the cardiovascular risk factors, the non-response rate was not
negligible. The aims of the present work were: 1) to investigate the representativeness of study sample to the
general population, and 2) to compare the known demographic and cardiovascular health-related profiles of
participants and non-participants.
Methods: For sample representativeness, the participants were compared to the source population according to
stratification criteria (age, sex and district of residence). Based on complementary information from the “medical
administrative database”, further analysis was carried out to assess whether the health status affected the response
rate. Several demographic and morbidity indicators were used in the univariate comparison between participants
and non-participants.
Results: Among the 4452 potentially eligible subjects contacted for the study, there were finally 1432 (32.2%)
participants. Compared to the source population, no differences were found for gender and district distribution. By
contrast, the youngest age group was under-represented while adults and elderly were over-represented in the
sample, for both genders. Globally, the investigated clinical profile of the non-participants was similar to that of
participants. Hospital admission and cardiovascular health-related medical measures were comparable in both
groups even after controlling for age. The participation rate was lower in Portuguese residents as compared to
Luxembourgish (OR = 0.58, 95% CI: 0.48-0.69). It was also significantly associated with the professional status (P <
0.0001). Subjects from the working class were less receptive to the study than those from other professional
categories.
Conclusion: The 32.2% participation rate obtained in the ORISCAV-LUX survey represents the realistic achievable
rate for this type of multiple-stage, nationwide, population-based surveys. It corresponds to the expected rate upon
which the sample size was calculated. Given the absence of discriminating health profiles between participants and
non-participants, it can be concluded that the response rate does not invalidate the results and allows generalizing
the findings for the population.
Background
Poor response rate and sample representativeness are
major concerns in prevalence public health surveys[1-5].
Nevertheless such studies are based on voluntary partici-
pation which depends basically on the subjects’ willing-
ness to take part. The literature shows that response
rates vary tremendously among surveys and are decreas-
ing in most industrialized countries[6]. In addition, the
participation to health surveys requiring physical,
anthropometric and blood examination of subjects tends
to be even lower in comparison to only-questionnaire
surveys[7-9]. Several factors affect the collaboration and
participation of subjects, such as population characteris-
tics, cultural attitudes, way of initial contact, length of
time needed for full participation, follow-up procedure,
legitimacy of the research from the subject’sv i e w p o i n t ,
* Correspondence: alaa.alkerwi@crp-sante.lu
1Centre de Recherche Public de la Santé, Centre d’Etudes en Santé, Grand-
Duchy of Luxembourg
Full list of author information is available at the end of the article
Alkerwi et al. BMC Medical Research Methodology 2010, 10:80
http://www.biomedcentral.com/1471-2288/10/80
© 2010 Alkerwi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and subject’s interest by the research topic[7-9]. Note-
worthy, only few published studies drew attention to the
real denominator (total eligible sample) to calculate the
true participation rate. This makes a comparison of
response rates across similar studies quite difficult.
Traditionally, a high response rate is dictated as a rule
of thumb of good survey practice. It is considered as an
indicator of quality survey estimates, by presuming that
a high response rate is associated with a more represen-
tative sample and hence with lower bias[10]. Though
several studies showed that non-response can yield
information with large potential bias[11,12], recent
empirical findings, based on relevant methodological
studies by Groves and colleagues, suggest however that
changes in non-response rates do not necessarily alter
survey estimates. The link between non-response rate
and bias is indirect and more complex[6]. More and
more, there is less support for the hypothesis that low
response rate produces systematically high non-response
bias estimates[6,13,10,14-16]. Moreover, the same group
of experts in the field advised to anticipate the coverage
error by applying a prior well-defined sampling frame so
as to retain the value of unbiased sample despite low
response rates[6,14,13]. In short, non-response bias is a
much more complex phenomenon than mere non-
response rates, which needs to be investigated consis-
tently in epidemiological surveys[17]. The literature
shows that non response is generally managed in two
ways. The first is by using response-enhancement strate-
gies during survey development and data collection.
This approach is to influence positively the response
rate[14,18], particularly among those initially reluctant,
as for example incentives for participation and remin-
ders to non-responders[19-22]. The second approach is
the post-survey adjustment of data using weighting tech-
niques to correct for non-response errors[18].
Observation of Cardiovascular Risk Factors in Luxem-
bourg (ORISCAV-LUX) is a nationwide cross-sectional
cardiovascular monitoring survey, conducted between
November 2007 and January 2009, under the auspices of
Luxembourg’s Ministry of Health and co-financed by
the Ministry of Research. Its major public health objec-
tive was to establish baseline information on the preva-
lence of various potentially modifiable cardiovascular
risk factors among the non-institutionalized general
adult population, aged 18-69 years. Luxembourg is a
small country surrounded by Belgium, France and Ger-
many, with a total population of 493,500 inhabitants
(STATEC official estimate, 2009) over an area of about
2,600 km
2. Luxembourgish people constitute approxi-
mately 56.3% of the population, while the well-inte-
grated foreign residents, constituting more than 150
nationalities, are mostly Portuguese (16.2%), French
(5.8%), Italians (3.9%) and Belgians (3.4%).
The response rate attained 30% in the ORISCAV-LUX
survey. However, the low participation rate does not
necessarily result in a selection bias[23,24]. Ideally, a
separate investigation on non-participants is recom-
mended to reveal potential outcome differences that
might indicate reasons for non-participation and subse-
quent potential non-participation bias[5,23]. To address
this concern, the present paper aimed to 1) investigate
the representativeness of the ORISCAV-LUX sample
w i t hr e s p e c tt ot h eg e n e r a lp o p u l a t i o n ,a n d2 )c o m p a r e
the known demographic and cardiovascular health-
related characteristics of participants and non
participants.
Methods
Overview of the survey
The ORISCAV-LUX survey was primarily designed to
collect baseline cardiovascular health data from adult
subjects aged 18-69 years residing in Luxembourg. Such
an epidemiological survey was never undertaken before
in this country. Its methodology is described in detail
elsewhere[25]. Basically, a representative random sample
was drawn from the national health insurance registry,
stratified by gender (male and female), age (5-year cate-
gories) and geographic districts of residence (Luxem-
bourg, Diekirch and Grevenmacher). With a 98% social
coverage rate, the registry is considered as the most
complete list of inhabitants available in Luxembourg.
The minimal representative sample size was calculated
to 1285 subjects to ensure statistical power[26]. How-
ever, based on literature review and previous evidence
with such multiple-stage population-based studies, a
high non-participation rate was expected, including refu-
sal, invalid addresses and non-response. Assuming a
response rate of 30% and a proportion of 5% of institu-
tionalized subjects in each stratum, the sample size was
augmented to 4496 subjects. The distribution of selected
subjects in each stratum was proportional to their distri-
bution in the source population (adult population of 18
to 69 years residents in Luxembourg). Pregnant women,
people living in institutions, subjects outside the age
range 18-69 years and those deceased before recruit-
ment were excluded. Briefly, full participation included
three major stages: (i) self completion questionnaire on
demographic and socio-economic status, personal and
family history of cardiovascular diseases and relevant
cardiovascular risk factors including tobacco and alcohol
consumption, physical activity, dietary habits and medi-
cation intake; (ii) physical and anthropometric measure-
ments; and (iii) blood, urine and hair tests.
Measures to increase participation
Intensive efforts were made to increase the response
rate, not only during survey preparation but also during
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survey publicity, including flyers and media articles,
were diffused to provide the selected individuals ample
information about the study objectives, relevance to
public health policies, ways of participation and partici-
pant’s rights. A telephone number for inquiries was sup-
p l i e da n dt h eO R I S C A V - L U Xw e b s i t ew a ss e tu p .A
detailed personal invitation letter with a prepaid reply
envelope addressed to the research centre was enclosed
with each mailing. The selected subjects were asked to
send their approval and phone number for follow-up
contact and appointment; otherwise, they were
requested to mention the reason of refusal with the pur-
pose of obtaining a prior idea on the reasons of non-
participation.
Up to three written invitations (first letter and 2
reminders) were sent at monthly intervals to those who
d i dn o tr e s p o n ds p o n t a n e o u s l y .T h e yw e r ef o l l o w e db y
several telephone contacts by skilled personnel, in order
to recruit the remaining non-respondents. Those who
refused were not contacted again. The field-nurses and
phone interviewers were all trained and supplied with
detailed manuals. Reluctant cases were followed up by
the project manager by means of personal phone con-
tact, to discuss the potential reasons and give them the
opportunity to ask further questions about the study. To
ensure smooth and well organized data collection, sev-
eral investigation centers dispatched all over the national
territory were prepared to welcome the participants,
every morning and occasionally on Saturdays. Home vis-
its were also proposed to those who had transport diffi-
culties related to their health status.
Due to the cultural diversity in Luxembourg, all docu-
ments (invitation letter, coupon-answer, consent and
questionnaires) were translated into the three most spo-
ken languages: German, Portuguese and English. The
translated questionnaires, originally established in
French, were independently back-ward translated into
French to ensure the validity[27]. Multi-lingual field-
nurses and phone interviewers were employed. These
measures were taken to increase the potential participa-
tion of the minorities. Another method of increasing
response rate was providing anonymity to the subject,
by using only research identification number and code-
bar for each participant’s file. A clear sentence was writ-
ten over the communicated documents, pointing out the
approval of the national ethical committee and the
national council for private data protection. In addition,
mutual benefit theory was applied, aiming to maximize
the participation, by supplying the participants with
their biological results complemented by the cardiologist
notes. In case of abnormal findings, they were advised
to consult their family doctor.
Complementary information
The General Inspectorate of Social Security (IGSS) of
Luxembourg manages the national health insurance reg-
istry, also called the “medical administrative database”,
from which the ORISCAV-LUX sample of 4496 subjects
was selected. Interestingly, besides information about
the name, gender, age group, nationality, professional
status and address of every resident in Luxembourg, the
register contains hospital discharge and medications
consumption data. Therefore, complementary anon-
ymous information from the “medical administrative
database” was obtained by means of subsequent official
request to the IGSS for both participants (1432 subjects)
and non-participants (3018 subjects). The requested
data concerned cardiovascular health-related conditions,
such as medications intake, hospital admissions and
medical measures recorded in year 2006 prior to recruit-
ment. Specifically, the requested information comprised
(i) prescribed medications, including anti-diabetics, anti-
thrombotics, cardiac therapy, antihypertensive drugs,
diuretics, peripheral vasodilatators, vasoprotective
agents, beta-blocking agents, calcium channel blockers,
agents acting on the renin-angiotensin system and
serum lipid reducing agents; (ii) hospitalizations due to
chronic conditions, such as malignant neoplasm of the
colon, bronchus, lung, prostate, breast, thyroid; mental
and behavioral disorders due to use of tobacco, alcohol
and nutritional disorders, severe mental retardation,
hypertensive diseases, ischemic heart disease, cardiac
arrest, cardiac failure, cerebro-vascular disease, athero-
sclerosis, chronic liver cirrhosis, acute and chronic renal
failure, and (iii) other cardiovascular-related medical
measures, such as hemodialysis for renal failure, cardiac
pacemaker, thyroid gland scintigraphy, cardiac catheteri-
zation and coronary angioplasty. These data are indica-
tors of morbidity covering a time period of 12 months
prior to the study launch. Information concerning the
distribution of the resident population of Luxembourg
was available freely from the National Statistics and Eco-
nomic Studies Service (STATEC).
Ethical aspects
As long as the additional requested data were anon-
ymous, the participant’s consent was not necessary to
make the link between data collected through the ORIS-
CAV-LUX survey and the medical administrative
database.
Statistical methods
All statistical analyses were carried out using the SAS
9.2 (
© SAS Institute Inc., Cary, NC, USA). Results were
presented as numbers and percentages. To study the
ORISCAV-LUX sample representativeness, the sample
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distributions according to the stratification criteria (sex,
age and district of residence) by classical chi-squared
tests. To test whether demographics characteristics and
health status affected the participation rate, participants
and non-participants were compared by univariate logis-
tic regression analysis. The dependent variable was the
participation to the ORISCAV-LUX study while the
independent variables were, respectively, prescribed
medication, hospitalization (yes or no), cardiovascular
health-related medical measures (yes or no), nationality
and professional status. Associations were expressed as
odds ratios (OR) together with their 95% confidence
interval (CI). Age-adjusted ORs were also computed by
logistic regression analysis to account for the effect of
age. All tests were two-sided, with a P-value of 0.05 or
less considered statistically significant.
Results
Recruitment process
The ORISCAV-LUX subjects’ recruitment process is
depicted in Figure 1. Among the 4496 subjects consti-
tuting the random stratified sample drawn from the
Luxembourg population, 12 were institutionalised and
therefore excluded (primary exclusion before sending
the invitation letter). After invitation, other 32 cases,
including pregnant women (N = 21), severe mentally ill
individuals (N = 5), one prisoner and 5 deceased sub-
jects were also excluded before recruitment (secondary
exclusion). Thus, a total of 4452 subjects were poten-
tially eligible to take part in the study.
Nearly 5% (213 subjects) were no longer residing at
their home address, identified by the post office as
“return to sender”, were classified as invalid addresses.
Further, 502 subjects (11.3%) absolutely refused to parti-
cipate and were labeled as negative answers; 1545
(34.7%) subjects replied positively and were classified as
positive answers; the 2192 (49.2%) individuals who never
returned the response-coupon despite 3 invitation letters
were considered as “non-respondents”. Among initially
positive answers, 80 persons refused to continue, were
listed as “withdrawal cases”, in addition to 31 subjects
couldn’t come to repeated appointments because of una-
vailability. The “invalid addresses”, “negative answers”,
“non-respondents”, “withdrawal cases” and those how
couldn’t participate were grouped in a single category
called “non-participation”, constituting 67.8% of the eli-
gible sample. Finally, a totalo f1 4 3 4( 3 2 . 2 % )w a ss u c -
cessfully recruited, hence achieving the prior calculated
sample size and the expected response rate. Two partici-
pants reached 70 years of age at the time of recruitment
were excluded later from the analysis (tertiary
exclusion).
Table 1 shows the impact of response-enhancement
measures on participation rate. The two postal remin-
ders and the repeated phone contacts enabled further
recruitment of 323 (7.3%) and 37 subjects (0.8%),
respectively. Thus the participation rate was increased
from 24% (1072/4452), then to 31.3% (1395/4452) and
finally up to 32.2 (1432/4452) until the end of the study.
A majority of subjects who refused to participate
("negative answers”, n = 392; 78.1%) did not indicate the
reason. For those who did, the reasons were: lack of
time to participate (33 cases), prolonged absence in par-
ticular for university students abroad (44 cases), perma-
nent medical control (23 cases), personal reasons (5
cases) and absence of interest in the topic (3 cases).
Sample representativeness
To assess the representativeness, the recruited sample
(1432 participants) was compared to the source popula-
tion (298,521 individuals) according to the stratification
criteria: gender, age category and district of residence.
As seen in Table 2, the ORISCAV-LUX sample was
representative of the population for gender and district
of residence, but not for age categories. This age differ-
ence was significant for both men (P = 0.0004) and
women (P = 0.0003). Compared to the source popula-
tion, the younger age group of 18-29 years was under-
represented, whereas adults and elderly were over-repre-
sented in the sample.
Comparison of participants and non-participants
The purpose of the non-response analysis was to com-
pare the known demographic and cardiovascular health-
related characteristics of participants and non-partici-
pants, to reveal potential outcome differences that might
indicate a non-response bias. The distribution between
participants and non-participants was comparable in
terms of the cardiovascular morbidity indicators, includ-
ing prescribed medications, hospital admission and med-
ical measures (Table 3). Globally, the clinical profile was
not dissimilar to that of participants. Concerning pre-
scribed medications, the OR was 1.4 (95%CI: 1.13 -
1.73) for serum lipid reducing agents medication, show-
ing a significant difference between participants and
non-participants (10.7% versus 7.89%, P = 0.002), but
this association disappeared after age adjustment (P =
0.12). All prescribed medications in participants were
generally similar to those in non participants after age
adjustment, except for calcium channel blockers (P =
0.04) and for anti-diabetic medications (P =0 . 0 4 9 ) .T h e
odds ratios for hospital admission (OR = 0.54, 95%CI:
0.26 - 1.13) and for cardiovascular health-related medi-
cal measures (OR = 1.16, 95%CI: 0.69 - 1.93) did not
reveal any significant association with participation, even
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pital admission (P = 0.05).
The recruited sample was representative of the source
population with respect to nationality (P = 0.40) (data
not shown). However, as seen in Table 3, the participa-
tion was significantly associated with the nationality (P
< 0.0001). The participation rate was lower in Portu-
guese residents as compared to Luxembourgish (OR =
0.58, 95% CI, 0.48-0.69).
Similarly, the participation was significantly associated
with the professional status (P < 0.0001). There were
1.12% farmers, 31.56% employees, 10.82% state employ-
ees, 2.37% independent intellectual workers, 21.51%
from working class among participants against 0.7%,
26.24%, 7.12%, 1.76% and 28.79%, respectively, among
non-participants. All ORs were statistically significant,
except for the “independent intellectual” category. After
age-adjustment, the OR for “farmer” category was no
longer significant. Overall, only subjects from the “work-
ing class” category were less receptive to the study as
compared to the other professional categories.
Discussion
As non-participation can affect the validity of epidemio-
logical studies, assessment of non-respondents charac-
teristics is important in the critical appraisal of health
research. For the same reason, the application of effec-
tive strategies to increase response could improve the
quality of health surveys and may reduce selection bias.
The key objectives of this paper were to analyze the
sample representativeness, and to test the null hypoth-
esis that response rate is not influenced by known
demographic or health-related characteristics. In addi-
tion, it purposed to assess the impact of pro-active mea-
sures to increase participation to the national
ORISCAV-LUX survey.
In spite of all the forethought and persistence efforts,
there are almost always some uncooperative individuals
who fail to respond[5]. The two postal reminders
enabled further recruitment of 323 subjects, leading to
7.3% increase in response rate. Further, 37 subjects
accepted to participate following repeated phone con-
tacts, hence raising the participation rate from 24% up
to 32.2% at the end of the study. Whatever the cause,
non-respondents may not be a random subgroup and
the respondents may not be representative of the parent
population. A recent systematic review[28] has exam-
ined ways to enhance the response rate, including perso-
nalized letters of invitation originating from universities
or public authorities, carefull a y o u ta n du s e r - f r i e n d l y
questionnaires, stamped return envelopes, follow up
contacts. Indeed, in the ORISCAV-LUX survey, almost
all these measures were applied. Likewise, from our
experience, we could suggest that multilingual personnel
and documents translations, particularly the question-
naire, to another non-official language(s), augmented
considerably the participation of those who prefer
answering in their mother language. Moreover, sending
by posted mail the cardiologist’s feedback regarding clin-
ical and biological results proved to be attractive to the
Figure 1 The ORISCAV-LUX subject’sr e c r u i t m e n tf l o w c h a r t .
Primary exclusion before invitation includes 12 addresses of
institutionalized subjects. Secondary exclusion after sending the
invitation letter includes 32 subjects (pregnant women, mentally ill
and deceased cases). Tertiary exclusion from the database after
recruitment (> 69 years old).
Table 1 The impact of response-enhancement measures on participation rate (Eligible participants = 4452 subjects)
Response-enhancement measures Number of positive answers Participation rate
First invitation 1072 24.1%
Two reminders 323 7.3%
Repeated phone calls 37 0.8%
Total participants 1432 32.2%
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to mention otherwise the reason of refusal was helpful
as a prior exploration of non-participation. Though the
majority of those who refused (negative answers) did
not indicate the cause, several reasons were nonetheless
expressed by the subjects, such as: lack of time to parti-
cipate, prolonged absence of young 18-29 years adults
doing their university studies abroad, which was con-
firmed by the under-participation level in this age
group. The recent research developments in the field of
population surveys in such small country made the
population more solicited and hence keen to participate
only to interesting topics. Individuals under permanent
medical control seemed to be less disposed and less
convinced by the necessity to participate to such sur-
veys. Other personal reasons and absence of interest to
the topic were also pointed out.
The main goal of obtaining higher response rates in
epidemiological studies is to increase the likelihood of
sample representativeness and to decrease “selection
bias” [26,29], also denoted “non-response bias” in the
text. The sample representativeness analysis have shown
that there was no significant difference of the recruited
ORISCAV-LUX sample by gender and district of resi-
dence as compared with the source population, but the
study sample contained a slightly higher proportion of
older population and less young adults. This finding was
expected as most of the young adults were not available
due to their prolonged absence for studying abroad. In
addition, the cardiovascular focus of the ORISCAV-LUX
study might not be a priority for young age groups who
usually enjoy a good health. Conversely, the over-repre-
sentativeness of the older people might be reasonably
due to their perception for the need to clinical check-
up, especially when counseling by a cardiologist was
provided freely. Therefore, in the ORISCAV-LUX sur-
vey, the potential consequence of age-related non-
response bias was handled by adjusting the sample for
age, by using the most recent available distribution of
the Luxembourg’s population (STATEC database).
According to the research questions, future analyses will
be performed after sample weighting to take into
account the complex sampling design.
Empirically, a low response rate does not necessarily
result in a biased sample or, conversely, a high response
rate may yield a biased sample[6,30]. In practice, an
“acceptable” or “tolerable” level of non-participation
cannot be generalized, because it depends on the study
nature, population characteristics and the event under
investigation[5]. Although in certain studies a small
amount of bias may distort the results, the extent of
bias should not necessarily be proportional to the non-
response rate[5,6]. In order to address this issue prop-
erly, it is necessary to obtain information about the
characteristics of non-participants[31].
The literature provides insights regarding the charac-
teristics associated with lower participation, including
younger[32] or older age[33,34], female sex[33,34], lower
socio-economic status[4,35], lower occupational status
[36], non-Western origin[37], comorbidity[38,39], and
less favorable lifestyle[40,41]. These findings vary mark-
edly according to the setting, study topic, method and
number of contacts, characteristics of the target popula-
tion and the available data for participants-non partici-
pants profile comparison.
It was reported that those who participate in clinical
trials and respond to public health surveys are generally
healthier and at less risk than those who refuse partici-
pation, also called the “healthy participant
effect”[1,8,38,42-44], though an example of opposite
findings was noticed[45]. To this end, it was important
to investigate the morbidity profile of non-participants
in the ORISCAV-LUX population. Globally, the morbid-
ity profile-related difference between the participants
and non-participants was not significant. Though the
participants under lipid-reducing agents were propor-
tionally more numerous than the non-participants, this
divergence (dissimilarities of the fractions of the exposed
and non-exposed)[35] disappeared after age adjustment.
Table 2 Comparison of ORISCAV-LUX participants to the
source population by gender, age category and district
of residence
Stratification criteria Source population
(N = 298521)
% (n)
Participants
(n = 1432)
% (n)
P-value
Gender 0.19
Women 49.64 (148,087) 51.33 (735)
Men 50.39 (150,434) 48.67 (697)
Age category (years)
Women < 0.0001
18-29 22.38% (33141) 15.6% (115)
30-39 25.57%(37865) 24.5% (180)
40-49 21.91% (32451) 24.9% (183)
50-59 16.41% (24309) 20.3% (149)
60-69 13.72% (20321) 14.7% (108)
Men < 0.0001
18-29 22.34% (33619) 15.2% (106)
30-39 25.72% (38699) 24.5% (171)
40-49 22.47% (33811) 27.1% (189)
50-59 17.08% (25700) 19.4% (135)
60-69 12.37% (18605) 13.8% (96)
District of residence 0.82
Luxembourg 73.74 (220,116) 72.97 (1045)
Diekirch 14.76 (43,956) 15.08 (216)
Grevenmacher 11.53 (34,449) 11.94 (171)
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Characteristics Participants
(N = 1432)
% (n)
Non-
Participants
(N = 3018)
% (n)
OR 95% CI P-
value
Age adjusted
OR
95% CI P-value
Prescribed medication
Anti-diabetics 2.79 (40) 3.38 (102) 0.82 0.57 -
1.19
0.30 0.68* 0.47 - 1.0 0.049
Anti-thrombotics 7.82 (112) 6.89 (208) 1.15 0.90 -
1.46
0.26 0.99 0.78 -
1.28
0.98
Cardiac therapy 3.56 (51) 3.71 (112) 0.96 0.68 -
1.34
0.81 0.89 0.63 -
1.25
0.48
Antihypertensive drugs 0.56 (8) 0.56 (17) 0.99 0.43 -
2.30
0.98 0.86 0.37 -
2.02
0.73
Diuretics 3.91 (56) 3.64 (110) 1.08 0.78 -
1.50
0.66 0.92 0.66 -
1.29
0.62
Vasoprotective agents 3.14 (45) 2.62 (79) 1.21 0.83 -
1.75
0.32 1.12 0.77 -
1.63
0.55
Beta blocking Agents 6.49 (93) 6.36 (192) 1.02 0.79 -
1.32
0.87 0.85 0.66- 1.12 0.25
Calcium channel blockers 2.37 (34) 3.02 (91) 0.78 0.53 -
1.17
0.23 0.65* 0.43 -
0.98
0.041
Agents acting on the renin-angiotensin
system
8.94 (128) 8.68 (262) 1.03 0.83 -
1.29
0.78 0.83 0.65 -
1.05
0.13
Serum lipid reducing agents 10.7 (153) 7.89 (238) 1.40* 1.13 -
1.73
0.0021 1.20 0.95 -
1.52
0.12
Hospitalization 0.63 (9) 1.16 (35) 0.54 0.26 -
1.13
0.10 0.48* 0.23 - 1.0 0.050
Cardiovascular health-related medical measures 1.61 (23) 1.39 (42) 1.16 0.69 -
1.93
0.58 1.06 0.63 -
1.78
0.83
Nationality <
0.0001
<
0.0001
Luxembourgish 62.08 (889) 54.37 (1641) Reference Reference
Portuguese 13.62 (195) 20.71 (625) 0.58* 0.48 -
0.69
<
0.0001
0.59* 0.49 -
0.71
<
0.0001
French 5.38 (77) 5.77 (174) 0.82 0.62 -
1.08
0.16 0.81 0.61 -
1.07
0.15
Italian 3.56 (51) 4.01 (121) 0.78 0.56 -
1.09
0.14 0.74 0.53 -
1.04
0.084
Belgian 3.77 (54) 3.08 (93) 1.07 0.76 -
1.51
0.69 1.05 0.74 -
1.49
0.78
Other 11.59 (166) 12.06 (364) 0.84 0.69 -
1.03
0.093 0.84 0.68 -
1.03
0.085
Professional status <
0.0001
<
0.0001
Farmer 1.12 (16) 0.70 (21) 2.15* 1.11 -
4.17
0.024 1.95 1.0 - 3.79 0.050
Employee 31.56 (452) 26.24 (792) 1.61* 1.35 -
1.92
<
0.0001
1.60* 1.34 -
1.91
<
0.0001
State employee 10.82 (155) 7.12 (215) 2.03* 1.59 - 2.6 <
0.0001
1.94* 1.52 -
2.48
<
0.0001
Independent 2.44 (35) 2.49 (75) 1.32 0.86 -
2.01
0.20 1.17 0.77 -
1.79
0.46
Working-class 21.51 (308) 28.79 (869) Reference Reference
Independent intellectual worker 2.37 (34) 1.76 (53) 1.81* 1.15 -
2.84
0.0097 1.66* 1.06 -
2.61
0.030
Other 30.17 (432) 32.90 (993) 1.28* 1.03 -
1.46
0.019 1.22* 1.02 -
1.46
0.030
* Odd ratio is significant when P-value < 5% level. The referent category is participation in the ORISCAV-LUX study for dependent variable. The referent category
is prescribed medication, hospitalization and medical measures for the independent variables.
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CAV-LUX survey was not related to the morbidity
profile.
Compared to non-participants, participants tended to
be older people of Luxembourgish nationality, working
as employees or state employees. Across the literature,
age seems to have a varying effect[46]; participation
either increased with age[37,47,48] or, in the contrary,
was higher among the young groups[19,49]. The age dif-
ference was probably related to different awareness of
the cardiovascular disease problems between young and
old people. Such aspects appear to be less attractive to
younger age group. In addition, Luxembourg is a small
country with limited local higher education possibilities;
most young adults of 18-29 years were not available
during the study period. Our intensive efforts to fix
appointments during the holiday periods increased mod-
erately their participation, but could not surmount their
under-representativeness in the sample.
Job grade showed that the probability of participation
among state employees was 2.03 times higher than that
of those coming from working-classes and 1.94 times
after age-adjustment. This finding is close to that
observed in most other similar studies in France[46],
Great Britain[5,50,51] and United States[52]. The diffi-
culty to get temporary free leave from work may hence
limit the attendance of working-class group.
Strengths and limitations
The present comparative study has major strong points.
First, we analyzed non-participation not only according
to traditional demographic background but also accord-
ing to cardiovascular health characteristics. Second, the
comparison study was based on reliable data obtained
by means of a request to official authorities, without the
need of prior research authorization or subject’sc o n -
sent. Third, the national health insurance authorities
keep a reasonably complete “medical administrative
database” of the general resident population of the
country. For health care reimbursement purposes, this
database is subject to regular updates, which was con-
firmed by the relatively low number of invalid addresses.
This enabled us to select a national representative sam-
ple and to obtain further information on the main cardi-
ovascular health-related conditions. In view of high cost
and low or even possibly decreasing participation rates
in population surveys, data collected from ongoing rou-
tine databanks may represent a good alternative option
for health monitoring in the future.
In ORISCAV-LUX, it was not possible to apply a
short version of the original self-reported health beha-
viors questionnaire as an alternative approach to obtain
information about the salient outcome indicators (smok-
ing, alcohol consumption, dietary habits and physical
activity). For the reason that, after all enhanced efforts
to contact and recruit the non-respondents and reluc-
tant cases, it was irrational to re-contact them for an
otherwise shorter questionnaire. According to the best
of our knowledge, no previous cardiovascular popula-
tion-based study has reported a similar methodology,
based on survey data and national “medical administra-
tive database”.
T h eI G S Sd a t ac o u l dn o ts u p p l yi n f o r m a t i o na b o u t
some relevant socioeconomic features, such as the edu-
cation level, income and marital status, which can be
seen as a limitation. Such information would allow
investigating the impact of socio-economic differences
and its potential bias on the non-participation rate[35].
Therefore, in future analyses, this issue should be inter-
preted prudently.
Conclusion
In conclusion, the present article provides an insight
regarding the strategies applied to increase response
rate, sample representativeness and the characteristics of
non participants. The 32.2% participation rate obtained
represents the realistic achievable for this type of survey,
corresponding to the expected rate, upon which the
sample size was calculated. The potential non-response
bias of the ORISCAV-LUX data was determined by the
degree of similarities between the characteristics of par-
ticipants and non-participants. Given the absence of
divergent cardiovascular health-related profiles, we con-
cluded that the response rate did not invalidate our data
and allows generalizing the results for the population.
Collectively, these results suggest that pro-active strate-
gies to increase response rate in health surveys may
yield unbiased estimates of entire population
characteristics.
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